Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note

Zacks Zacks Abrir en Zacks
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note

In the latest trading session, Oscar Health, Inc. (OSCR) closed at $15.29, marking a -1.23% move from the previous day. This move lagged the S&P 500's daily gain of 1.18%. Meanwhile, the Dow experienced a rise of 0.66%, and the technology-dominated Nasdaq saw an increase of 1.96%.

Prior to today's trading, shares of the company had gained 16.57% outpaced the Finance sector's gain of 4.89% and the S&P 500's gain of 3.93%.

The investment community will be closely monitoring the performance of Oscar Health, Inc. in its forthcoming earnings report. The company is scheduled to release its earnings on May 6, 2026. On that day, Oscar Health, Inc. is projected to report earnings of $1.21 per share, which would represent year-over-year growth of 31.52%. Simultaneously, our latest consensus estimate expects the revenue to be $4.89 billion, showing a 60.62% escalation compared to the year-ago quarter.

For the full year, the Zacks Consensus Estimates project earnings of $0.2 per share and a revenue of $18.91 billion, demonstrating changes of +111.83% and +61.62%, respectively, from the preceding year.

It is also important to note the recent changes to analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Right now, Oscar Health, Inc. possesses a Zacks Rank of #3 (Hold).

In terms of valuation, Oscar Health, Inc. is presently being traded at a Forward P/E ratio of 76.13. This signifies a premium in comparison to the average Forward P/E of 9.78 for its industry.

The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 97, placing it within the top 40% of over 250 industries.

The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.

See

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Oscar Health, Inc. (OSCR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research